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Summary
Background: Recent work has highlighted the importance of
the recycling of endocytic membranes to the intercellular
bridge for completion of cytokinesis in animal cells. ADP-
ribosylation factor 6 (ARF6), which localizes to the plasma
membrane and endosomal compartments, regulates endo-
cytic recycling to the bridge during cytokinesis and is required
for abscission.
Results: Here, we report that the JNK-interacting proteins
JIP3 and JIP4, two highly related scaffolding proteins for
JNK signaling modules, also acting as binding partners of
kinesin-1 and dynactin complex, can function as downstream
effectors of ARF6. In vitro, binding of GTP-ARF6 to the second
leucine zipper domain of JIP3 and JIP4 interferes with JIPs’
association with kinesin-1, whereas it favors JIPs’ interaction
with the dynactin complex. With protein silencing by small
interfering RNA and dominant inhibition approaches, we
show that ARF6, JIP4, kinesin-1, and the dynactin complex
control the trafficking of recycling endosomes in and out of
the intercellular bridge and are necessary for abscission.
Conclusion: Our findings reveal a novel function for ARF6 as
a regulatory switch for motor proteins of opposing direction
that controls trafficking of endocytic vesicles within the inter-
cellular bridge in a mechanism required for abscission.
Introduction
During cytokinesis in animal cells, dynamic remodeling in actin
and membrane drives the ingression of the cleavage furrow to
form a narrow cytoplasmic bridge between two daughter cells,
filled with antiparallel interdigitated microtubule (MT) bundles
[1]. In a final step called abscission, cleavage of the intercellular
*Correspondence: philippe.chavrier@curie.frbridge allows separation of the two daughter cells. Several
studies have demonstrated that targeted traffic of secretory
and endocytic recycling vesicles at the ingressing furrow and
within the bridge is required for abscission (reviewed in
[2, 3]). Along this line, Rab11 and ADP-ribosylation factor 6
(ARF6), two small G proteins regulating endocytic recycling
[4, 5], have been shown to work synergistically during cytoki-
nesis because interfering with their functions results in defects
ranging from cytokinesis delay to block of abscission and
generation of binucleated cells [6–12].
The function of Rab11 and ARF6 at the midbody involves
a scaffolding protein called FIP3 that forms ternary complexes
with Rab11 and ARF6 [9, 10, 13]. In addition, the exocyst
complex, an ARF6 and Rab11 effector controlling docking of
vesicles at the plasma membrane [14–16], is also essential
for membrane delivery during cytokinesis [10, 17]. Based on
these findings and on the transient activation of ARF6 at the
midbody during cytokinesis [6], it was argued that GTP-
ARF6 may drive tethering of Rab11/FIP3-positive recycling
endosomes (REs) to the midbody [10, 13].
In this study, we identified the structurally related c-Jun-
N-terminal-kinase interacting protein 3 (JIP3, also known as
MAPK8IP3, JSAP1, and SYD2) and JIP4 (also known as JLP,
SPAG9, and SYD1) as novel effectors of activated ARF6. In
addition to their role as scaffolding proteins in the JNK/
mitogen-activated protein kinases (MAPK) pathway [18–20],
JIP3 and JIP4 family proteins have been implicated in an
evolutionarily conserved mechanism of bidirectional move-
ment of axonal vesicles through their interactions with the
kinesin light chain (KLC) subunit of kinesin-1 and with the
dynactin complex [21–25]. We found that ARF6, through its
binding to JIP3 and JIP4, regulates the interactions of JIP
proteins with kinesin-1 and dynactin/dynein motors in a mech-
anism that controls the trafficking of endosomes in and out of
the intercellular bridge during cytokinesis.
Results
GTP-ARF6 Interacts with the LZII Domain of JIP3 and JIP4
We identified several clones encoding a conserved domain of
the highly related JIP3 and JIP4 proteins in a yeast two-hybrid
screen by using a GTP-locked mutant of ARF6 (ARF6-Q67L)
as bait (see Supplemental Data and Figure S1 available
online). A two-hybrid screen with Drosophila ARF6-Q67L
also identified the ortholog of JIP3 and JIP4, called Sunday
Driver (SYD) (Figure S1). Comparison of JIP3, JIP4, and SYD
two-hybrid clones defined a minimum ARF6-binding domain
corresponding to amino acids 312–507 of human JIP3
(ARF6BD) (Figures 1A and S1).
In pull-down assays, glutathione S-transferase (GST)-JIP3/
312–507 recovered specifically ARF6-Q67L, but not the inac-
tive ARF6 mutant form (ARF6-T27N) nor active and inactive
forms of ARF1 or ARF5 (Figure 1B). In addition, purified
recombinant GTP-ARF6, but not GDP-ARF6, bound to JIP3/
312–507 or to the ARF-binding domain of ARHGAP21
(ArfBD-GAP21 [26]) (Figures 1C and 1D), in contrast to GTP-
bound [D17]ARF1-Q71L that interacted only with ArfBD-
GAP21 (Figure 1D). These findings demonstrate a direct and
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185specific interaction of GTP-ARF6 with JIP3. The region of JIP3
that is necessary for interaction with GTP-ARF6 was further
narrowed down to amino acids 371–507, corresponding to
a second leucine zipper domain of the N terminus of JIP3
(JIP3/LZII) (Figures 1A and 1E). Similarly, the JIP4/LZII domain
(position 347–480) was able to retain HA-ARF6-Q67L, but not
ARF6-T27N in a pull-down assay (Figure 1E). In reciprocal
experiments, endogenous JIP4 from HeLa cell lysates was
pulled down on immobilized His6-tagged [D12]ARF6-Q67L
and not on [D12]ARF6-T27N (Figure 1F). Finally, GTP-bound
ARF6-Q67L, but not inactive ARF6-T27N, could be coimmuno-
precipitated with endogenous JIP4 from HeLa cell extracts
(Figure 1G). All together, these data clearly demonstrated
a direct and specific binding of GTP-ARF6 to the conserved
LZII domain of JIP3 and JIP4.
Endosomal Association of ARF6 and JIP4
JIP4, which has a broad tissue expression [27], was detected
in HeLa cells (Figure S2), in contrast to JIP3 that is predomi-
nantly expressed in neuronal cells (data not shown). RNA inter-
ference with two independent siRNAs efficiently depleted
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Figure 1. JIP3 and JIP4 Are Novel ARF6 Effectors
(A) Schematic representation of JIP3 and JIP4
proteins. The leucine zipper I (LZI) and LZII
domains (hatched regions), the ARF6-binding
domain defined by two-hybrid (gray box), and
the JNK-binding site (black box) are depicted.
(B) Pull-down assays of HA-tagged GTP-locked
(Q) or inactive (T) variants of ARF1, ARF5, or
ARF6 from HeLa cell lysates with GST-JIP3/312–
507 or GST. Bound proteins were detected with
anti-HA antibody.
(C) GST, GST-JIP3/312–507, or GST-ArfBD/
GAP21 on beads were incubated with GDP-
loaded or GTP-loaded recombinant ARF6. Bound
proteins were detected with anti-ARF6 anti-
bodies.
(D) GST, GST-JIP3/312–507, or GST-ArfBD/
GAP21 were incubated with recombinant GTP-
loaded [D17]ARF1-Q71L, and pull-down was
performed as in (C). ARF1 was detected with
anti-ARF1 antibody.
(E) Pull-down assays of HA-tagged ARF6 variants
from HeLa cell lysates with GST-JIP3/LZII, GST-
JIP4/LZII, or GST. Bound material was analyzed
as in (B).
(F) HeLa cells were transfected or not with GFP-
JIP3/LZII, and cell lysates were incubated with
His6-tagged [D12]ARF6-Q67L or [D12]ARF6-
T27N. Bound proteins were analyzed with anti-
JIP4 (upper panel) or anti-GFP antibodies (lower
panel).
(G) Lysates of HeLa cells expressing HA-tagged
ARF6-Q67L (Q) or ARF6-T27N (T) were immuno-
precipitated with indicated antibodies. Precipi-
tates were analyzed with anti-JIP4 or anti-HA anti-
body. Data are representative of two to three
independent experiments.
JIP4 (Figure S2A). The distribution
of JIP4 could not be assessed by
immunofluorescence because of lack
of antibodies and overexpressed JIP4
(or JIP3) gave a strong diffuse cytosolic
staining (data not shown). However,
a fraction of JIP4 (7.5% of cytosolic
levels) was found in a high-speed
membrane pellet after ultracentrifugation of HeLa cell homog-
enates (Figure S2B, lane 7). Interestingly, membrane-associ-
ated JIP4 was reduced in cells depleted of ARF6 (4.1-fold 6
0.2), suggesting that ARF6 controls JIP4’s association with
membranes (Figure S2B, compare lanes 7 and 9). When
analyzed by subcellular fractionation (see Experimental Proce-
dures), JIP4 was detected in the endosomal fraction with
enrichment similar to that of Rab5 (Figure S2C). Of note,
kinesin-1 and dynein have also been detected in the early
endosome fraction by using the same fractionation procedure
[28]. In agreement with previous data [29], we found no
enrichment of ARF6 in the endosome fraction (Figure S2C).
We conclude that a fraction of JIP4 is associated with an
endosomal compartment in HeLa cells possibly in an ARF6-
dependent manner.
In Vitro Regulation of JIP3’s and JIP4’s Association
with Microtubule Motors by GTP-ARF6
Recently, the LZII domains of JIP3 and JIP4 were found to
mediate interaction with the tetratricopeptide repeat (TPR)
domain of the light chain of the microtubule motor protein
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Figure 2. GTP-ARF6 Controls the Association of JIP3 and JIP4 with Kinesin-1 and Dynactin Complex
(A) GST-JIP3/LZII bound to beads was incubated with His6-tagged TPR domain of KLC1 in the absence (lanes 1 and 8) or in the presence of His6-tagged
[D12]ARF6-Q67L (lanes 3–7 and 9) or [D12]ARF6-T27N (lane 10). Bound material was analyzed with anti-His tag antibodies (upper panel, His6-TPR,w37 kDa;
middle panel, His6-ARF6,w21 kDa). Lower panel shows unbound His6-ARF6-Q67L or His6-ARF6-T27N added in the assay (input, 10% of total).
(B) Pull-down assay of kinesin heavy chain (KHC) from HeLa cell lysates incubated with GST (lane 2) or GST-JIP4/LZII (lanes 3–6) in the presence of His6-
[D12]ARF6-Q67L as indicated.
(C) Lysates of HeLa cells expressing V5-tagged JIP3 or the N-terminal region of JIP3 (aa 1–507) were immunoprecipitated with control IgGs or anti-V5 anti-
bodies. Precipitates were analyzed with anti-p150Glued antibody.
(D) Pull-down assays of endogenous ARF6 and p150Glued from HeLa cell lysates with GST, GST-JIP3/LZI, GST-JIP3/312–507, or GST-JIP3/LZII. Bound
proteins were analyzed with anti-p150Glued or anti-ARF6 antibody.
(E) Pull-down assays of p150Glued from HeLa cell lysates performed with GST (lanes 1–4) or GST-JIP3/LZII (lanes 5–14) in the absence (lanes 1 and 5) or in the
presence of indicated amount of His6-tagged [D12]ARF6-Q67L (lanes 6–8) or [D12]ARF6-T27N (lane 9) or His6-tagged TPR (lanes 10–12). Bound proteins
were detected with anti-p150Glued or His-tag antibodies.
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187kinesin-1 (KLC1) [21, 24, 27]. Figure 2A (lane 1) shows binding
of recombinant purified His6-tagged TPR domain of human
KLC1 to GST-JIP3/LZII immobilized on beads. The LZII
domain of JIP3 and JIP4 is relatively large, comprising nine
heptad repeats of leucine residues [24], implying that this
domain may interact with several partners and raising the
question of whether GTP-ARF6 and KLC1 can bind simulta-
neously to JIP3 or JIP4.
Binding of His6-TPR to GST-JIP3/LZII was dose dependent,
reaching a plateau at 4 mM of His6-TPR for 2 mM GST-JIP3/LZII
immobilized on beads (data not shown). By using these
concentrations of His6-TPR and GST-JIP3/LZII, we observed
a dose-dependent reduction of binding of KLC (TPR domain)
to the LZII domain of JIP3 by increasing concentrations
of [D12]ARF6-Q67L (Figure 2A, lanes 3–7). In contrast,
[D12]ARF6-T27N, which does not bind JIP3/LZII, had no
such competitive effect (Figure 2A, compare lanes 9 and 10).
Similar observations were made by using the LZII domain of
JIP4 (data not shown). Moreover, GTP-ARF6 interfered with
binding of kinesin heavy chain to the LZII domain of JIP4 in
a dose-dependent manner (Figure 2B). These results demon-
strate that binding of GTP-ARF6 or kinesin-1 on the LZII
domain of JIP3 and JIP4 is mutually exclusive, consistent
with a competition mechanism between activated ARF6 and
kinesin-1 for binding to JIP3 or JIP4.
Mouse JIP3 associates with the p50/dynamitin and
p150Glued subunits of the dynactin complex and colocalizes
partially with dynein on axonal vesicles of mouse sciatic nerve
[25]. However, the domain of JIP3 contributing to its associa-
tion with the dynactin subunits has not been determined.
Immunoprecipitation of V5-tagged human JIP3 from lysates
of transfected cells confirmed the association with p150Glued
(Figure 2C, lower panel). In addition, we found that the
N-terminal region of JIP3 (position 1–507) including the LZI/
LZII domains was sufficient for this association (Figure 2C,
upper panel). To determine more precisely the binding site of
p150Glued, we performed pull-down assays with GST fusion
proteins corresponding to various fragments of the N-terminal
region of JIP3. p150Glued and p50 subunits were specifically
retained on constructs comprising the LZII domain of JIP3
(Figure 2D, upper panel, and data not shown) and JIP4
(Figure 2F, lane 7). In addition, endogenous ARF6 (GTP bound)
was retained on JIP3/LZII domain-containing constructs
(Figure 2D, lower panel).
We then analyzed the consequence of ARF6 or KLC1
binding to the LZII domain of JIP3 and JIP4 on its association
with dynactin. The presence of increasing concentrations of
His6-TPR domain of KLC1 inhibited binding of p150Glued to
JIP3/LZII in a dose-dependent manner (Figure 2E, upper
panel, compare lanes 5 and 10–12), demonstrating a mutually
exclusive association of KLC1 or dynactin with JIP3. On the
contrary, binding of increasing amounts of ARF6-Q67L to
GST-JIP3/LZII enhanced association of p150Glued to JIP3/
LZII (Figure 2E, upper panel, compare lanes 5 and 6–8, and
2F, compare lanes 1 and 2–6). At 30 mM ARF6-Q67L, binding
of p150Glued to GST-JIP3/LZII was increased 4.63-fold 6 1.36
(from three independent experiments). This stimulatory effect
was observed at a low concentration of ARF6-Q67L (1 mM)
(Figure 2F, compare lanes 1 and 2) and was specific for the
active form of ARF6 because addition of 30 mM ARF6-T27N
did not affect binding of p150Glued to GST-JIP3/LZII(F) Pull-down assay of p150Glued from HeLa cell lysates incubated with GST
increasing amounts of His6-[D12]ARF6-Q67L as indicated. Data presented a(Figure 2E, compare lanes 5 and 9). Similarly, ARF6-Q67L
stimulated binding of p150Glued to the LZII domain of JIP4
(Figure 2F, compare lanes 7 and 8–10).
All together, our results show that kinesin-1 and the dynactin
complex can interact with the second leucine zipper domain
of JIP3 and JIP4 and that these interactions are mutually
exclusive. In addition, we found that GTP-bound ARF6, by
binding to the LZII domain of JIP3 and JIP4, promotes and
stabilizes LZII association with dynactin while antagonizing
binding of kinesin-1.
The ARF6/JIP4 Pathway Is Involved in Completion
of Cytokinesis
Given the regulation of JIPs’ interactions with MT motors by
ARF6, we investigated whether JIP4 might act downstream
of ARF6 to control MT-dependent endosomal membrane
movement to the midbody during cytokinesis.
We scored cytokinesis in HeLa cells silenced for ARF6, JIP4,
and the light (KLC1) or heavy chain (KIF5B) of kinesin-1 or
p150Glued dynactin subunit by using siRNA treatment
(Figure S2A). Cells were synchronized with a nocodazole block
and then fixed and stained for DNA and MT at various times
following release from nocodazole arrest at G2/M. Control
cells exhibited the highest number of midbodies 2 hr after
release; the number then dropped abruptly after 4 and 6 hr
as cells completed abscission (data not shown). In contrast,
in cell populations depleted for JIP4, ARF6, KLC1, or KIF5B,
the proportion of cells at cytokinesis at 2 hr was reduced
and remained sustained over time (data not shown). In agree-
ment with the function of the dynactin complex in early mitosis
[30], depletion of p150Glued caused a high proportion of aber-
rant spindles during the first 2 hr after nocodazole release,
with a low proportion of cells at cytokinesis. However, after
4 hr of release, a low proportion of p150Glued-depleted cells
went through mitosis and started cytokinesis, and this propor-
tion remained unchanged after 6 hr, suggesting that late
stages of mitosis were also affected by knockdown of
p150Glued, as recently reported for Drosophila p150Glued [31]
(data not shown).
All together, these data were suggestive of reduced
synchrony or cytokinesis delay in the depleted cell popula-
tions. This issue was addressed by performing live imaging
of individual cells after nocodazole washout and monitoring
bridge severing. Abscission occurred w2 hr (120 min 6 28)
after the onset of furrowing in mock-treated cells (see
Figure 3A and MovieS1). Knockdown of JIP4, ARF6, and
KLC1 did not affect furrowing but, rather, delayed abscission,
resulting in anw2-fold increase of the time required for abscis-
sion that was completed w250–270 min after the onset of
furrowing (Figure 3A and Movie S2). In addition, we observed
that 14% of ARF6-depleted cells underwent furrow regression
and fused back, as compared to 4% in control or other cell
populations (Figure 3B and Movie S3). This broader effect of
ARF6 knockdown, which is consistent with the previous
observation that ARF6 loss correlates with increased
frequency of binucleated cells [8], reflects probably ARF6’s
hierarchical position in the pathway. Finally, in the p150Glued
depleted cell population, the proportion of cells completing
cytokinesis was low, and these also showed an increase in
the time required for abscission (217 min 6 50) (Figure 3A).-JIP3/LZII (lanes 1–6) or GST-JIP4/LZII (lanes 7–10) in the presence or not of
re representative of three independent experiments.
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188A B Figure 3. Silencing of ARF6, JIP4, KLC1, and p150Glued
Delays Abscission
HeLa cells were treated with the indicated siRNAs, and, after
48 hr, cells were synchronized by overnight treatment with 10
mM nocodazole. The drug was then washed out, and indi-
vidual cells were analyzed by phase contrast microscopy
for bridge severing (A) or furrow regression and fusion-
back (B).
(A) Data represent the mean time (min) 6 SEM between the
onset of furrowing and abscission (n, number of cells
analyzed; *p < 0.001 compared to mock-treated cells,
t test). Cells undergoing furrow regression and fusing back
were not included in this analysis.
(B) Cells were scored for furrow regression and fusion-back
(n, number of cells analyzed).Regulation of Tfn/FIP3-Positive Endosome Distribution
by ARF6, JIP4, and Motors during Cytokinesis
The delay in cytokinesis in cells with reduced levels of ARF6 or
JIP4 raised the question of whether an ARF6/JIP4 mechanism
may act to control the recycling of endosomes to the midbody.
Endosome distribution during cytokinesis was analyzed in
synchronized cells incubated with Alexa488-Tf for 4 hr after
nocodazole release. As previously described [32], cells at cyto-
kinesis showed twin clusters of giantin-positive membranes:
one at the edge of the midbody (Figure 4A, dots) and one
distal to the midbody (Figure 4A, asterisks). Similarly, pairs of
Tf-positive endosomal clusters were observed at the distal
pole of daughter cells and adjacent to the midbody [33]
(Figure 4A, middle panel). In contrast to proximal Golgi clusters
that never penetrated the bridge (Figure 4B, see higher magni-
fication), Tf-positive endosomes accumulated at the edges and
within the bridge (Figure 4B, see arrowheads in the middle
panel). Accumulation of endosomes within the bridge was
confirmed by electron microscopy of synchronized cells
allowed to progress through mitosis in the presence of exter-
nally added HRP-conjugated Tf (Figure S3A). Tubulovesicular
endosomes positive for HRP-Tf were visible at the edge and
within the bridge (Figure S3A, arrows), sometimes aligned on
spindle MTs (Figure S3A, arrowheads). The central midbody
region was free of endosomes. As shown previously [9, 10, 34],
FIP3 was associated with recycling endosomes at the edge and
within the intercellular bridge, whereas Lamp1-positive late
endocytic/lysosomal structures were absent from the bridge
(Figures S4A and S4B).
We quantified the fraction of Tf (or FIP3) accumulating in the
intercellular bridge defined by anti-a-tubulin staining in
comparison to the total amount of Tf (or FIP3) present in
a region passing through the center of the two daughter cells’
nucleus and distal endosome cluster (see Figure 4D). Image
analysis showed that about 40% of internalized Tf was
concentrated in the midbody region in control cells (either
mock treated or treated with irrelevant siMT1) (Figure 4E).
Similar quantifications were performed in cells depleted for
ARF6, JIP4, or the motors. Clusters of endosomes were
retained at the distal poles of daughter cells depleted for
ARF6, whereas proximal clusters at the edge of the central
spindle and endosomes in the midbody were strongly
reduced, as compared to mock-treated cells (Figure 4C).
Quantification showed an w2-fold reduction in Tf present in
the midbody region, as compared to controls (Figure 4E).
JIP4-depleted cells at cytokinesis showed a scattered distri-
bution of endosomes with no obvious clustering and midbody
accumulation (Figure 4C). This effect was correlated with
an w2-fold reduction in the amount of Tf present in themidbody region (Figure 4E). Depletion of the dynactin subunit
p150Glued led to an even stronger phenotype with complete
scattering of Tf-positive endosome and Golgi clusters and
reduced accumulation of endosomes in the intercellular bridge
(Figures 4C and 4E). Finally, although depletion of KLC1 or
KIF5B did not affect Tf endosome clustering, Tf-positive endo-
somes were rarely observed in the intercellular bridge and
were retained at the far edge of the central spindle corre-
sponding to MT minus ends (Figures 4C and 4E and data not
shown). Altogether, these data suggest that kinesin-1 controls
primarily plus end-directed movement of endosomes within
the bridge in cytokinesis cells.
Similarly, quantification of FIP3 endosome distribution
demonstrated an w2-fold reduction in the bridge of cells
depleted for ARF6, JIP4, KLC1, or p150Glued, as compared to
mock-treated cells (Figure S4C), indicating that the ARF6/JIP
pathway controls trafficking of Tf/FIP3 endosomes during
cytokinesis.
ARF6, JIP4, and Motors Work Together to Control
Abscission
The effects of ARF6, JIP4, and dynactin/kinesin-1 motor
silencing on the distribution of endosomes within the intercel-
lular bridge and on abscission, together with our biochemical
data, are supporting a mechanism whereby these molecules,
acting in concert, regulate the trafficking of Tf/FIP3 endo-
somes during cytokinesis. In order to have more formal
evidence of a common mechanism of action of ARF6, JIP4,
and motors, we performed several experiments.
First, overexpression of the isolated TPR domain of KLC1
induced a 2.8-fold increase in the number of cells at cytoki-
nesis and a concomitant decrease in the number of Tf endo-
somes in the bridge area (Figures 5A and 5B). These inhibitory
effects of TPR were almost fully rescued by coexpression of
JIP3, indicating that the dominant inhibitory effect of TPR on
cytokinesis is mainly mediated through a specific inhibition
of endogenous KLC1/JIP interaction (Figures 5A–5C).
A second set of experiments made use of several ARF6
mutants to establish the ARF6/JIP mechanism at cytokinesis.
In agreement with previously published results [6], overex-
pression of GTP-locked ARF6-Q67L mutant resulted in
a strong (w7-fold) increase of cells blocked at cytokinesis
(Figure 5F). ARF6-Q67L accumulated mostly at the plasma
membrane and on some aggregates in the midbody region
(Figure S5A, arrowheads) [6, 10]. The distribution of Tf endo-
somes in proximal and distal clusters was lost in ARF6-
Q67L-expressing cells, although Tf endosomes were still
observed within the bridge (Figures 5G and S5A, arrows).
Expression of dominant inhibitory ARF6-T27N mutant also
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kinesis (Figure 5F) while causing a depletion of endosomes in
the bridge (Figures 5G and S5B). All together, these findings
demonstrate that not only ARF6 activity, which is inhibited
by expression of ARF6-T27N acting on ARF6-guanine
exchange factors (GEFs), but also GTP hydrolysis on ARF6,
is required for completion of cytokinesis. ARF6-Q67L, which
is known to inhibit several ARF6-dependent cellular functions
[35–37], is likely to act negatively by trapping downstream
effectors in unproductive complexes for cytokinesis.
In order to test directly the requirement for ARF6/JIP interac-
tion during cytokinesis, we generated a chimeric ARF protein
by swapping the interswitch region between ARF6 and ARF1
(ARF6iSW) because this region contributes to interactions
with upstream and downstream ARF partners (Figure 5D)
[38]. When assessed by pull-down assay, ARF6iSW-Q67L
(with an additional Q67L mutation to lock it in a GTP-activated
conformation) retained a full capacity to interact with ARH-
GAP21 (Figure 5E). This was expected because ARHGAP21
is an effector common to both ARF1 and ARF6 that depends
on identical residues between the two ARFs for binding
(Figure 5D) [26, 39]. Strikingly, whereas ARF6iSW-Q67L
Figure 4. Depletion of Tf-Positive Recycling En-
dosomes at the Midbody in siRNA-Treated Cells
(A) HeLa cells synchronized overnight with noco-
dazole were incubated with Alexa488-Tf (green
in the merge image) for 4 hr after nocodazole
washout and fixed and stained for a-tubulin
(blue) and giantin (red). Twin clusters of giantin-
positive vesicles and Tf-positive endosomes,
positioned proximally (dots) and distally (aster-
isks) to the midbody, are indicated. Scale bar
represents 5 mm.
(B) Higher magnification of the midbody region
boxed in (A). Scale bar represents 1 mm.
(C) Midbody region of HeLa cells treated with the
indicated siRNA and synchronized and stained as
in (A). Full-size pictures are shown in Figure S3.
Scale bar represents 1 mm.
(D) HeLa cells as in (A) were incubated with
Alexa546-Tf (red) and stained for a-tubulin (green)
and DNA (blue). Fluorescence intensity of inter-
nalized Tf was analyzed with the Linescan module
of Metamorph software along a region (dashed
line) overlapping the midbody based on MT stain-
ing and extending up to distal endosome clusters
opposite to the nuclei.
(E) Intensity of internalized Tf in the midbody
region measured as in (D) in cells treated with
the indicated siRNA. Twenty cells from two inde-
pendent experiments were analyzed for each
condition. Data are expressed as the mean
percentage of Tf in the midbody area compared
to total Tf in the selected region 6 SEM (*p <
0.001 compared to mock-treated cells, t test).
effectively bound to the ARF6-binding
domain of FIP3, binding to the LZII
domain of JIP4 was completely abol-
ished (Figure 5E). Of note, GTP loading
on ARF6iSW was stimulated by the
ARF6-specific GEF, EFA6, to an extent
similar to that of wild-type ARF6, indi-
cating that ARF6iSW responds to ARF6
upstream activating stimulus (data not
shown). When overexpressed in HeLa
cells, ARF6iSW led to a 3-fold increase of cells at cytokinesis,
as compared to wild-type ARF6 (Figure 5F), and correlated
with a reduction of endosomes in the intercellular bridge
(Figures 5G and S5C). Therefore, specific uncoupling of
ARF6 from JIP in ARF6iSW-expressing cells leads to cytoki-
nesis defects similar to those observed when ARF6 or JIP
function was inhibited, demonstrating that these proteins
work together during abscission.
Finally, we analyzed the localization of p150Glued in HeLa
cells at cytokinesis and found that p150Glued colocalized with
the central spindle marker MKLP2 (Rabkinesin6) on both sides
of the midbody (Figure 6A). Strikingly, depletion of ARF6 or
JIP4, but not KLC1, led to a significant reduction of midbody
accumulation of p150Glued, as compared to MKLP2 (Figures
6A and 6B). In addition, overexpression of dominant-negative
ARF6-T27N also led to decreased accumulation of p150Glued
in the midbody, opposite to ARF6-Q67L expression that
induced a low but significant increase in p150Glued localization
at the midzone (Figures 6C and 6D). All together, these results
are consistent with a role for ARF6/JIP4 in regulating the
association of p150Glued/dynactin with central spindle MTs in
cytokinesis cells.
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during Cytokinesis
Confocal spinning disk live imaging of fluorescent Tf-labeled en-
dosomes in HeLa at cytokinesis revealed highly dynamic
tubulovesicular structures at the edge and within the intercellular
bridge with plus and minus end-directed movements following
linear trajectories (see Movie S4). The vesicles carrying Tf in the
plus enddirectionmovedata rateof0.4260.2mm/s, comparable
to published rates for motor-driven, MT-dependent endosome
transport [40]. The dynamics of Tf endosomes in the midbody
were analyzed by fluorescence recovery after photobleaching
(FRAP). After photobleaching of A488-Tf in the midbody region
Figure 5. JIP4 Coupling to KLC and ARF6 Controls Completion of Cytokinesis
(A) HeLa cells transfected with GFP, GFP-JIP3, or TPR-V5, as indicated, were incubated with Alexa546-Tf, fixed and stained for V5-tag, a-tubulin, and DNA
(data not shown). The percentage of cells at cytokinesis was scored. Six hundred GFP-positive cells or 300 GFP-JIP3, TPR-V5, or double-positive cells were
analyzed from three independent experiments. Graph shows the mean percentage of transfected cells at cytokinesis 6 SEM.
(B) Mean percentage of Tf in the midbody of same cells as in (A) compared to total Tf in a selected region, as in Figure 4D6SEM (20 cells from two independent
experiments for each construct). In (A) and (B), *p < 0.001 compared to GFP-transfected cells; *p < 0.001 between TPR-V5 and GFP-JIP3 + TPR-V5, t test.
(C) Cell lysates were immunoblotted with the indicated antibodies.
(D) Sequence alignment of the switch and interswitch domains of human ARF6 and ARF1 (numbering according to ARF6). The sequence of chimeric ARF6iSW
is shown at the bottom. Residues involved in the interaction with ARHGAP21 are underlined [39]. Binding capacity of ARF proteins with ARHGAP21, JIP4, or
FIP3 is summarized (+, binding; 2, no binding; nd, not determined).
(E) Pull-down assays of HA-tagged ARF6-Q67L or ARF6iSW-Q67L from HeLa cell lysates with GST-ArfBD/GAP21, JIP4/LZII, or FIP3/607–756. Bound proteins
were detected with anti-HA antibody. Data are representative of three independent experiments.
(F) HeLa cells transfected with the indicated ARF6 constructs were incubated with Alexa546-Tf, fixed and stained for HA-tag, a-tubulin, and DNA (data not
shown). Mean percentage of transfected cells at cytokinesis6 SEM compared to nontransfected (NT) cells from the same fields. Three hundred transfected
cells were analyzed for each construct from three independent experiments and compared to 600 NT cells.
(G) Mean percentage of Tf in the midbody area compared to total Tf in a selected region determined as in Figure 4D6 SEM (20 cells from two independent
experiments for each construct). In (F) and (G), *p < 0.001 compared to NT cells; *p < 0.001 between ARF6iSW and ARF6-expressing cells, t test.
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191(Figure 7A), fluorescence recovery reached a plateau corre-
sponding tow80% of initial fluorescence with a mean half-time
recoveryofw35s (calculated from21midbodies inmock-treated
cells) (see Experimental Procedures and Figure 7B).
FRAP experiments were repeated in ARF6, JIP4, KLC1, or
p150Glued-depleted cells. We inferred that, although steady-
state distribution of Tf endosomes differed in these various
cell populations (see Figures 4 and S3), comparison of fluores-
cence recovery parameters should provide useful information
on the role of theseproteins inendosomedynamicsduring cyto-
kinesis.KLC1 depletion had noeffect on the mobile fraction ofTf
as compared to mock treatment (plateau atw85% of fluores-
cent before bleaching) (see Figure 7C). However, T1/2 was
increasedw1.5-fold (w53 s), suggesting that plus end-directed
movement was slowed down upon reduced expression of KLC1
(see model in Figure 7D). In contrast, depletion of p150Glued did
not affect T1/2 (w34 s) but significantly decreased the mobile
fraction of Tf (59% recovery) (see Figure 7c). Our interpretation
of this finding is that reduced levels of p150Glued/dynactin
impaired minus end-directed movement and clearance of Tf en-
dosomes from the midbody area, thus inhibiting endosome
turnover (see Figure 7D). Interestingly, JIP4 depletion affected
both T1/2 and the mobile fraction; plus end-directed movement
was slowed down (T1/2w51 s), and the fraction ofmobileTf was
Figure 6. ARF6 and JIP4 Are Required for
p150Glued Recruitment at the Midbody during
Cytokinesis
(A) HeLa cells treated or not with a siRNA for
ARF6 were synchronized overnight with nocoda-
zole, and, 4 hr after washout, cells were fixed and
stained for p150Glued and MKLP2/rabkinesin6.
Scale bar represents 5 mm.
(B) Ratio of fluorescence intensity of p150Glued to
MKLP2 in the midbody region (arbitrary unit) 6
SEM. Ratio of p150Glued/MKLP2 intensities was
arbitrarily set to 1 in mock-treated cells. Twenty
cells from two independent experiments were
analyzed for each condition (**p < 0.001
compared to mock-treated cells, t test).
(C) HeLa cells transfected with HA-tagged ARF6-
Q67L or ARF6-T27N were stained for p150Glued,
MKLP2, and HA-tag (data not shown).
(D) Ratio of p150Glued/MKLP2 fluorescence inten-
sities 6 SEM measured as in (B) in ARF6-Q67L-
expressing or ARF6-T27N-expressing cells as
compared to NT cells (**p < 0.001 compared to
NTcells, *p<0.05, t test).Scalebar represents5mm.
decreased (61% recovery) (Figures 7B
and 7C). Finally, ARF6 knockdown, like
p150Glued, affected only the mobile frac-
tionofTf (64%recovery) withoutaffecting
T1/2 (w27 s) (see Figure 7C). All together,
these findings suggest that JIP4 func-
tions in both plus and minus end move-
ment of endosomes, whereas loss of
ARF6 activity affects primarily movement
out of the midbody (Figure 7D).
Discussion
Here, we identified a novel mechanism
through which ARF6 may control the
directionality of MT-based movements
depending on dynein/dynactin and
kinesin-1 motors. This is based on a highly specific interaction
of GTP-bound ARF6 with the second conserved leucine zipper
domain of JIP3 or JIP4. This domain had previously been
shown to mediate binding of mammalian JIP3 and JIP4 and
Drosophila SYD to the carboxy-terminal TPR domain of the
light chain of kinesin-1 (KLC) [21, 22, 24]. In addition, we iden-
tified the LZII domain as the binding site for p150Glued and p50
dynactin complex subunits. We found that there are two
consequences of binding ARF6 to JIP3 and JIP4. First, GTP-
ARF6 competes with kinesin-1 for binding to JIP3 or JIP4.
Second, it favors a complex of JIP3 or JIP4 with dynactin.
When ARF6 is inactive (i.e., GDP loaded), JIP3 and JIP4 would
be free to interact with kinesin-1 and to move along toward MT
plus ends. Kinesin-1 is responsible for plus end-directed
movement of early endosomes in several cell types [28, 41–
44]. It is not known whether JIP3 and JIP4 binding to KLC1
contributes to endosome movement by regulating kinesin-1
activity, similar to the role of the related JIP1 protein, or by
mediating attachment of the motor on vesicular cargo [22,
45]. Upon activation of ARF6 by Sec7 family ARF6-GEFs [5,
46] and interaction of GTP-ARF6 with JIP3 or JIP4, occurring
likely at the plasma membrane, kinesin-1 would be replaced
by dynactin on JIP3 or JIP4, switching movement of JIPs’
cargos toward MT minus ends.
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192Figure 7. ARF6 and JIP4 Regulate Kinesin-1/Dynactin-Dependent Trafficking in and out of the Intercellular Bridge
(A) Synchronized mitotic HeLa cells either mock treated or treated with JIP4 siRNA were incubated with Alexa488-Tf for 2–3 hr after nocodazole release. Fluo-
rescence is shown 6 s before bleach, immediately after bleaching (dashed region), and at the indicated times after bleaching. Scale bar represents 1 mm.
(B) Fluorescence recovery was recorded every second for 200 s after photobleaching. FRAP curves of mean intensity recovery expressed as percentage of
initial fluorescence calculated from 21 midbodies of mock-treated cells or 23 midbodies of JIP4-depleted cells from at least three independent experiments
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193We addressed the consequences of this novel ARF6/JIP-
dependent motor switch mechanism during late cytokinesis.
Polarized trafficking of endocytic vesicles toward the con-
necting bridge between two daughter cells has been identi-
fied as one major mechanism contributing to completion of
cytokinesis [2, 3]. Polarity within the bridge relies on two
MT bundles of opposite orientation with plus ends interdigi-
tating at the midbody. Our live-cell imaging and FRAP data
argue for MT-dependent trafficking of Tf-positive endosomes
moving in and out of the bridge. Our findings that silencing of
kinesin-1 and p150Glued dynactin subunit affects endosome
dynamics within the bridge and interferes with abscission
suggest that kinesin-1 and dynein are the motors responsible,
at least in part, for these movements. Additional mecha-
nism(s) may exist based on other MT and/or actin-dependent
motors such as myosin VI, which is required for abscission
and localizes on TfR-positive endosomes moving in and out
of the bridge [47].
Our findingsalso identify ARF6/JIP proteins as key regulators
of kinesin-1/dynein-dependent movements during cytokinesis.
Loss of ARF6 or JIP4 or perturbation of JIP4’s interactions with
ARF6 or KLC1 altered the dynamics and distribution of endo-
somes within the bridge and, similar to motors, reduced the
efficacy of abscission. Our observation that uncoupling of
ARF6/JIP4 (but not ARF6/FIP3) interaction with the ARF6iSW
mutant interferes with endosome dynamics and abscission
argues for different roles for GTP-ARF6 at the midbody. One
novel mechanism involves switching kinesin-1 to dynactin-
dynein motors on JIP4 to control movement of membrane
and protein components in and out of the bridge (see model
in Figure 7E). In parallel, coordinated roles for ARF6 and
Rab11 have been established in the trafficking and tethering
of endocytic vesicles originating from proximal Rab11- and
FIP3-positive endocytic clusters to the midbody [10, 11, 13].
This is based on dual interactions of Rab11 and ARF6 with adja-
cent regions of the extended carboxy-terminal coiled-coil
domain of FIP3 [13, 48, 49] and on Rab11 and ARF6 binding
to different subunits of the exocyst complex [10, 14, 15].
Although interaction of GTP-Rab11 with FIP3 is likely to
occur on proximal endosome clusters at the minus end of
central spindle MTs [9, 34], the question remains of where
ARF6 comes into the game. Our data demonstrate that traf-
ficking of (Rab11)/FIP3 endosomes to the plus ends of MTs
involves a kinesin-1/JIP4-dependent mechanism (Figures 7E
and S4C). Ternary complexes of GDP-ARF6:FIP3:Rab11 may
form on proximal endosomes as GDP-ARF6 binds FIP3 [13],
and this may ensure ARF6 targeting to the bridge before its
activation. Upon GTP loading on ARF6 by specific GEF(s) at
the bridge, movement out of the bridge would be allowed
through a dynein-dynactin/JIP4 switch mechanism required
for abscission. Interfering with components of the ARF6/JIP4
motor switch mechanism in our gene-silencing and ARF6mutant experiments (see Figure 7E) perturbs endosome
trafficking in and out of the bridge. Along this line, Nuf, the
Drosophila counterpart of FIP3, was recently reported to
undergo cycles of concentration and dispersion from the
MT minus ends depending on dynein in a process required
for endosome delivery during furrow formation [50]. Interest-
ingly, cytokinesis defects in cells with impaired JNK function
[51] suggest that regulation and localization of JNK and its
upstream regulatory kinases, known partners of JIPs, may
also be important for abscission. In agreement, we found
that pharmacological inhibition of JNK activity interfered with
abscission, similar to ARF6 or JIP4 loss of function (data not
shown). In addition to its role for membrane addition, ARF6/
JIP4-dependent bidirectional movement of endosomes may
have a qualitative importance during cytokinesis by targeting
specific components involved in dynamic remodelling and
stability of the bridge [3].
Experimental Procedures
Cell Culture and Mitotic Synchronization
HeLa cells (a gift from A. Dautry, Institut Pasteur, Paris, France) were grown
in DMEM supplemented with 10% fetal calf serum, 2 mM glutamine, and
150 mg/ml penicillin/streptomycin at 37C in 7% CO2. For cell synchroniza-
tion experiments, HeLa cells were treated overnight (16 hr) with 1 mM noco-
dazole (Calbiochem) at 37C. Then, cells were washed three times in
complete medium and incubated at 37C for the indicated period of time.
When indicated, cells were incubated in the presence of fluorescently
labeled human Tf (5 mg/ml) after release of nocodazole. Then, cells were
fixed and processed for immunofluorescence analysis.
Indirect Immunofluorescence and Deconvolution Microscopy
HeLa cells plated onto coverslips were fixed in 4% paraformaldehyde and
processed for immunofluorescence microscopy as described previously
[14]. For deconvolution microscopy, cells were examined under a motorized
upright wide-field microscope (Leica DMRA2). Acquisition was performed
with an oil immersion objective (3 100 PL APO HCX, 1.4 NA) and a cooled
interlined CCD detector (Roper CoolSnap HQ). Z positioning was accom-
plished with a piezo-electric driver (Physik Instrument, Karlsruhe, Germany)
mounted underneath the objective lens. The system was steered by Meta-
morph 6 Software (Universal Imaging Corporation, Downingtown, PA).
Z series of images (40 to 55 planes) were taken at 0.2 mm increments. Decon-
volution was performed by the 3D deconvolution Metamorph module with
the fast Iterative Constrained PSF-based algorithm [52].
FRAP Experiments
For FRAP experiments, HeLa cells stably expressing mCherry-a-tubulin
either mock treated or treated with the indicated siRNA for 72 hr were
synchronized by overnight treatment with nocodazole. Cells were incubated
for 2–3 hr with 5 mg/ml Alexa488-labeled human Tf after release of nocoda-
zole. Midbodies identified by mCherry-a-tubulin signal were photobleached
at full laser power with the 488 nm line from a 1W Argon laser inw100 ms.
The whole cell was acquired before and after photobleaching at 1 frame/s
during 200 s through a 1003 1.35 NA oil HCX Plan-Apo objective on a Leica
DMIRE2 inverted microscope with a Cascade II CCD camera (Roper), a Poly-
chrome V illumination device (Till Photonics), and Metamorph 7.1.7 software
(MDS). Background and observational photobleaching were correctedare shown (see Experimental Procedures). Error bars represent the standard deviations. Mean recovery and mean half-time recovery (T1/2, time correspond-
ing to 50% intensity recovery) are indicated.
(C) Mean intensity recovery (%) and T1/2 (s)6 SEM are indicated for cells treated with indicated siRNA (n, number of midbody analyzed from at least three
independent experiments).
(D) Schematic models of endosome dynamics in cells depleted for the indicated protein after bleaching. Only half of the bridge is represented. White dots
indicate bleached endosomes, and black dots indicate fluorescent endosomes. Dashed arrows indicate impaired movement of endosomes in the minus
or plus end direction.
(E) Hypothetical model for ARF6/JIP4 regulation of kinesin-1/dynactin-dependent trafficking in and out of the bridge. Rab11+/FIP3+ endosomes move within
the bridge toward the plus ends of central spindle microtubules via interaction with kinesin-1 in a JIP4-dependent manner. At the midbody, ARF6 is converted
in its GTP-bound form by specific ARF6-GEF(s) and interacts with effectors including FIP3 (and exocyst, data not shown), resulting in endosome docking to
the midbody. In parallel, ARF6 interacts with JIP4 favoring dynactin binding to JIP4 and movement of dynactin/dynein cargos (vesicles, JIP4, and partners,
etc.) out of the bridge. Steps inhibited by KLC1 (TPR) and ARF6 mutant constructs used in this study are indicated.
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194during the FRAP experiment. In addition, the fraction of photobleached
molecules during bleaching was quantified and used to properly set the
100% recovery plateau. After intensity corrections, quantification of FRAP
parameters was performed by monitoring the fluorescence intensity inside
the photobleached area during the FRAP experiment. Relative fluorescence
intensity in the bleached area expressed as a percentage of initial fluores-
cence was averaged from 20–25 cells for each cell population, and standard
deviation was calculated. The mean half-time recovery (T1/2) was deter-
mined numerically from the mean fluorescence recovery plots as the time
corresponding to 50% intensity recovery.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures, five
figures, and four movies and can be found with this article online at http://
www.current-biology.com/supplemental/S0960-9822(08)01698-9.
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